معرفی
Dr. Carlo Brugnara is a Professor in the Department of Laboratory Medicine at Boston Children's Hospital and Harvard Medical School. He serves as Director of the Hematology Laboratory and is Editor-in-Chief of the American Journal of Hematology. His research spans red blood cell physiology, sickle cell disease, thalassemia, and iron metabolism.
Research Interests: Dr. Brugnara's work focuses on ion transport in erythrocytes, particularly the role of transport proteins in sickle cell dehydration and novel therapeutic strategies. His research integrates molecular mechanisms, genetic determinants of red cell hydration, and clinical applications in pediatric hematology. He has pioneered the use of reticulocyte parameters for diagnosing iron deficiency and monitoring erythropoiesis.
Recent Research Trends: His recent publications highlight therapeutic innovations in hemoglobinopathies, including mitapivat for thalassemia and spherocytosis, omega-3 fatty acids for sickle cell vasculopathy, and resolvins for inflammatory cardiomyopathy. His work also extends to healthcare economics, digital hematology, and genetic modifiers of disease severity.
Scientific Awards and Recognition:
- Fellow, American Society of Clinical Investigation
- Fellow, Association of American Physicians
- Fellow, Academy of Clinical Laboratory Physicians and Scientists
- Editor-in-Chief, American Journal of Hematology (since 2007)
Advising and Grants: While specific students and grants are not listed, Dr. Brugnara has led extensive research programs funded by NIH and other agencies, mentoring numerous trainees in hematology and laboratory medicine. His editorial leadership has significantly shaped the field of hematology publishing.
Labs and Research Units: He leads research in the Hematology and Oncology Research Unit at Boston Children's Hospital, focusing on translational studies in red cell disorders and diagnostic innovation.
